CCN2 and Hepatic fibrosis: Although the full-length CTGF level is inversely correlated with the liver fibrosis stage in patients with FALD, it is possible that the changes in the full-length CTGF level may reflect the decrease in the platelet count due to progression of liver fibrosis because platelets contain full-length CTGF [7, 8].